Efficacy of Tenofovir Alafenamide versus placebo added to a failing regimen followed by treatment with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Atazanavir in HIV-1 positive, antiretroviral treatment-experienced adults

This is a phase III, two part study to evaluate the efficacy of Tenofovir Alafenamide versus…

Serological diagnosis of syphilis in HIV-infected patients: 10 years observation

This is a longitudinal, prospective cohort study to assess the prevalence of latent syphilis among HIV-infected…

A phase 3, randomized, double-blind study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 positive, antiretroviral treatment-naïve adults

Randomized, Double-Blind, multicenter, active-controlled study to evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/…

Evaluation of Mobile Interactive Supervised Therapy (MIST) for monitoring adherence to TB medication

This study will assess the feasibility, acceptability and efficacy of an electronic system for monitoring and…

An international observational study to characterize adults with influenza A – pandemic H1N1 (H1N1v) INSIGHT H1N1v outpatient study (FLU 002)

The purpose of this observational study is to describe participants in geographically diverse locations with influenza…

A phase 3 open-label safety study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide single-tablet regimen in HIV-1 positive patients with mild to moderate renal impairment

Open-label, multicenter, multi-cohort study to assess the safety, tolerability, and efficacy of a STR of E/C/F/TAF…

Metabolic disease and bone health in HIV positive patients compared to HIV uninfected

This is a five-year prospective cohort study that investigates the trends of morbidity and mortality among…

A phase 2/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate single tablet regimen (STR) in HIV-1 infected antiretroviral treatment-naive adolescents

This study is to evaluate the steady-state pharmacokinetics (PK) and confirm the dose of the elvitegravir/cobicistat/emtricitabine/tenofovir…

A phase 2b randomized, active-controlled, staged, open-label trial to investigate safety and efficacy of BMS-955176 in combination with Dolutegravir and Atazanavir (with or without Ritonavir) in treatment-experienced HIV-1 infected adults

This study will evaluate whether the combination of BMS-955176 with atazanavir (ATV) [with or without ritonavir…

Causes of discontinuity of tuberculosis treatment and strategies to improve the treatment outcomes of tuberculosis in University Hospital

This study will assess the causes of discontinuity of tuberculosis treatment and strategies to improve the…

A phase 3, open-label study to evaluate switching from a TDF-containing combination regimen to a TAF-containing combination single tablet regimen (STR) in virologically-suppressed, HIV-1 positive subjects

Randomized, open-label, multicenter, active-controlled study to evaluate the safety and efficacy of virologically suppressed subjects who…

LiveRLife

This is a pilot, healthy life campaign for HCV among ex- and current illicit drug users.

Maraviroc in kids

An open-label, multicenter, multiple-dose pharmacokinetic, safety and efficacy trial of maraviroc in combination with optimized background…

A phase 3 multicenter, double-blind, randomized, active comparator-controlled clinical trial to evaluate the safety and efficacy of reformulated Raltegravir 1200 mg once daily versus Raltegravir 400 mg twice daily, each in combination with TRUVADA™, in treatment-naïve HIV-1 infected subjects

This study will evaluate the safety and efficacy of reformulated raltegravir (MK-0518) 1200 mg once daily…

Stop C

This program will help develop and propel HCV treatment.